1000 IU Recombinant Human Erythropoietin Injection IP

Name: 1000 IU Recombinant Human Erythropoietin Injection IP
Brand: NEETCO BIOPHARMA
Price: 400 INR
Availability: InStock

Price 400 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

1000 IU Recombinant Human Erythropoietin Injection IP Specification

Suitable For
Adults, Children, Elderly

Solubility
Fully soluble in water

CAS No
113427-24-0

Molecular Formula
C815H1317N233O241S5 (based on EPO-alpha)

Dosage Guidelines
As directed by physician; typically administered subcutaneously or intravenously

Appearance
Clear, colorless to slightly yellowish solution

Pacakaging (Quantity Per Box)
1 Pre-filled Syringe per box

Assay
1000 IU/0.5ml (per syringe)

HS Code
3002

Purity
>98% (HPLC)

Melting Point
Not Applicable (protein solution)

Physical Form
Liquid (Sterile Solution)

Type
Pharmaceutical Injection

Ingredients
Recombinant Human Erythropoietin alfa, buffer solution, stabilizers

Feature
Recombinant Human Erythropoietin; Stimulates red blood cell production

Shelf Life
24 months from manufacturing date

Storage Instructions
Store at 2C to 8C; Do not freeze; Protect from light

Precautions
Monitor hemoglobin levels regularly; assess iron status prior to and during therapy

Side Effects
Hypertension, headache, injection site reactions, flu-like symptoms

Sterility
Sterile, pyrogen-free

Formulation Strength
1000 IU/ml

Prescription Status
Prescription required

Brand Name
As per manufacturer

Route of Administration
Intravenous or Subcutaneous

Uses
Treatment of anemia associated with chronic kidney disease, chemotherapy, or HIV therapy

Contraindications
Uncontrolled hypertension, known hypersensitivity to Erythropoietin

About 1000 IU Recombinant Human Erythropoietin Injection IP

Experience outstanding treatment with our 1000 IU Recombinant Human Erythropoietin Injection IP - available at an affordable price for a limited time. This distinguished product places anemia management in the spotlight, offering radiant benefits for individuals with chronic kidney disease, patients undergoing chemotherapy, or those with HIV therapy-induced anemia. Each pre-filled, sterile solution is formulated for intravenous or subcutaneous administration under a physician's guidance. Carefully manufactured to provide purity >98%, this prescription medication delivers consistent, reliable results while ensuring patient safety when monitored appropriately. Don't miss this exceptional solution distinguished by clinical excellence.

Versatile Application and Patient Suitability

1000 IU Recombinant Human Erythropoietin Injection IP is meticulously designed for use in treating anemia across diverse clinical settings such as nephrology, oncology, and HIV care. This pharmaceutical injection stimulates red blood cell production, making it suitable for adults, children, and the elderly. Its practical application in both hospital and clinical environments ensures adaptability, delivering outstanding therapeutic value to a broad spectrum of patients in need of effective anemia management.

Reliable Supply & Professional Packing

Benefit from seamless logistics and the assurance of timely packing & dispatch of 1000 IU Recombinant Human Erythropoietin Injection IP anywhere in India. Each pre-filled syringe is safely enclosed, ensuring the integrity of the product during transit. We provide detailed quotations upon inquiry, accommodating bulk and regular domestic orders. Our robust supply chain and packaging protocols reflect our dedication to operational excellence, elevating both product safeguarding and delivery efficiency for all clients.

FAQ's of 1000 IU Recombinant Human Erythropoietin Injection IP:

Q: How is 1000 IU Recombinant Human Erythropoietin Injection IP administered?

A: This injection is administered either intravenously or subcutaneously, as directed by a healthcare professional. Dosage and frequency depend on medical guidance.

Q: What conditions can be treated with this product?

A: It is indicated for the management of anemia associated with chronic kidney disease, chemotherapy, or HIV therapy.

Q: When should hemoglobin levels be monitored during therapy?

A: Hemoglobin levels should be monitored regularly both before and throughout the treatment to ensure safe and effective use.

Q: What precautions should be taken before starting therapy?

A: Patients should have their iron status assessed and ensure blood pressure is controlled prior to beginning therapy, as uncontrolled hypertension is a contraindication.

Q: Where is the product available for purchase and supply?

A: The injection is distributed, supplied, and exported across India. Quotation and supply details can be requested from the authorized distributor or supplier.